Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

9.42
Delayed Data
As of Mar 22
 +0.06 / +0.64%
Today’s Change
7.41
Today|||52-Week Range
15.49
+22.18%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close9.36
Today’s open9.37
Day’s range9.16 - 9.50
Volume132,711
Average volume (3 months)175,668
Market cap$352.3M
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)-10.56%
Earnings growth (this year)+68.58%
Earnings growth (next 5 years)--
Revenue growth (last year)-2.88%
P/E ratioNM
Price/Sales10.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.01-0.69%
AQXPAquinox Pharmaceutic...-0.39-2.52%
AKBAAkebia Therapeutics ...+0.17+1.90%
CCXIChemoCentryx Inc-0.14-1.92%
Data as of 03/22/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$25.2M
Annual profit (last year)-$103.1M
Net profit margin-409.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts


Search for Jobs